Synergistic interactions between cannabinoid and opioid analgesics.
about
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesCannabinoid and opioid interactions: implications for opiate dependence and withdrawalAM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studiesA pilot trial of low-dose naltrexone in primary progressive multiple sclerosismu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesisFunctional characterization of G-protein-coupled receptors: a bioinformatics approach.The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for painCannabinoid-opioid interactions during neuropathic pain and analgesia.Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter SurveyCannabinoid-opioid interaction in chronic pain.Impact of efficacy at the μ-opioid receptor on antinociceptive effects of combinations of μ-opioid receptor agonists and cannabinoid receptor agonists.Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.Colitis generates remote antinociception in rats: the role of the L-arginine/NO/cGMP/PKG/KATP pathway and involvement of cannabinoid and opioid systems.The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients Through a Written Document.Biological Significance of GPCR Heteromerization in the Neuro-Endocrine SystemSynergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647.Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.Ginseng pharmacology: a new paradigm based on gintonin-lysophosphatidic acid receptor interactions.The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociceptionAdditive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in ratsImpact of cannabis use during stabilization on methadone maintenance treatmentSingle dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability.Integrating cannabis into clinical cancer care.Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.Molecular mechanisms of opioid receptor-dependent signaling and behavior.On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulationA randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic painReceptor and channel heteromers as pain targets.Advances in the field of cannabinoid--opioid cross-talk.Emerging strategies for exploiting cannabinoid receptor agonists as medicines.Candidate genes for cannabis use disorders: findings, challenges and directionsShared mechanisms of alcohol and other drugs.A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems.Interactions between Δ(9)-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys.Migraine: an overview.The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids.Pharmacological Profiles of Oligomerized μ-Opioid Receptors.Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse
P2860
Q24623282-8DA59295-AF1B-4159-998A-BF534607F640Q27000762-CC7274FF-E518-4C72-A9A6-1D0DE839DE45Q28270589-7A3D323E-EF55-4301-A39E-6597920F64E4Q28291875-CFC9DD75-E505-47F6-9838-7B455DF06A44Q28591542-0C7D3AB7-94ED-4E5C-AAC0-B691B09469D7Q30009384-511FBC2E-F431-4893-9D1B-7D8FDA7735C8Q33578856-25391926-2567-42AF-94F5-EA18034ABFBFQ33637224-E5CE0A2D-B2BD-46B9-B18E-AE16F777704BQ34077887-90B81A9F-B16D-427B-9A09-5528F1D77708Q34229641-07B406B4-E4EE-4946-8C6F-3C728E3621A4Q34360705-CB2DA991-43C2-454F-9E51-79555ECD94A7Q34424009-59AA42B8-E721-4A06-8D9C-135AB8EA8F17Q35305940-802EC7EF-C7C5-41DF-819A-C7FB10C30277Q35563620-09635D6F-1F4E-4A54-B0A4-16FA22B2E82CQ35971498-096C79A3-CAA4-4726-8E71-F03A6C55CA6BQ36019444-BB4FFB80-EBBF-4609-B76A-1C8C70E2C290Q36089024-8CACFE62-2F64-4EB5-A530-2E7FB08C0B28Q36209242-BD716F03-6CEC-4302-AE23-71E5309C2B6BQ36341688-3B9C0E7F-44F1-4E62-A28B-51DFE4DC3733Q36344310-C18E3FC1-EDC4-491B-9121-4D29757CCC53Q36387010-A88CC819-3A70-4290-B004-2074F7F6F0A8Q36476801-46356052-9297-4814-9C18-B45027D6F0D9Q36618089-D04F7B9D-591E-4CE2-8EA0-09011D436AF8Q36685151-8515D396-DCC4-46F5-9C26-95AB659E660CQ36852565-12BE8B52-1B16-4EA0-AC4A-39553D63EEA8Q36852576-FC1E3DA2-68F6-4D37-9300-4AD564639DAFQ36974487-22CF11A5-0841-404A-A10F-D18A0766358CQ37061890-9CD4AE72-46D1-4D44-AE9E-FD84116E846DQ37141496-25E13E8E-2235-403F-8D5B-6EAA3AD7852BQ37148710-BC142B5F-3A14-4443-962D-878C6D30C397Q37164808-9F56AC65-6983-4777-9BA6-CA7BC02B69F3Q37230665-B700BAE4-0E97-4EC7-B520-AE02291599A6Q37245382-EB70F790-6A55-4E85-8BE3-5B46151D8996Q37386501-417A07D0-6646-442D-972D-002F570A35C4Q37523119-9C7E0A66-B4BF-4AEE-91DB-66F0BAAE5910Q37564992-973CFDB3-B45F-45A5-9534-71D28C8CC124Q37627183-CD839FB5-554F-4B6F-8507-A0D58E0DC519Q37646423-040D6D44-D3C2-443D-9058-8D9A905F968AQ37679197-88D4218A-FBD8-4FCD-8800-B0C8C2FF35EDQ37680038-6A3F3F94-17DB-471A-9F8C-ABE8221146D9
P2860
Synergistic interactions between cannabinoid and opioid analgesics.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Synergistic interactions between cannabinoid and opioid analgesics.
@ast
Synergistic interactions between cannabinoid and opioid analgesics.
@en
type
label
Synergistic interactions between cannabinoid and opioid analgesics.
@ast
Synergistic interactions between cannabinoid and opioid analgesics.
@en
prefLabel
Synergistic interactions between cannabinoid and opioid analgesics.
@ast
Synergistic interactions between cannabinoid and opioid analgesics.
@en
P1433
P1476
Synergistic interactions between cannabinoid and opioid analgesics.
@en
P2093
Diana L Cichewicz
P304
P356
10.1016/J.LFS.2003.09.038
P407
P577
2004-01-01T00:00:00Z